FdaApplication
ANDA 217640
Identifiers
- fda_app_no: ANDA217640
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2025-01-28 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 3MG | TABLET, FOR SUSPENSION;ORAL |
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET, FOR SUSPENSION;ORAL |
| EVEROLIMUS | EVEROLIMUS | 2MG | TABLET, FOR SUSPENSION;ORAL |
3 products